MedPath

Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer

Phase 2
Completed
Conditions
Cervical Cancer
Vaginal Cancer
Registration Number
NCT00002562
Lead Sponsor
Gynecologic Oncology Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with advanced, refractory, or recurrent cervical or vaginal cancer.

Detailed Description

OBJECTIVES: I. Estimate the frequency and duration of objective response, duration of progression-free interval, and survival of patients treated with paclitaxel for advanced, persistent, or recurrent clear cell adenocarcinoma of the vagina and cervix who have failed higher priority treatment protocols. II. Determine the frequency and severity of observed adverse effects on this study.

OUTLINE: Single-Agent Chemotherapy. Paclitaxel, TAX, NSC-673089.

PROJECTED ACCRUAL: 25 evaluable patients per histologic stratum will be accrued over 10-12 months for the nonsquamous cell carcinoma stratum and over 23 months for the clear cell adenocarcinoma stratum. If more than 3 patients in a given stratum respond, an additional 25 patients will be accrued to that stratum. As of 07/95, the study is open only to patients with clear cell adenocarcinoma of the vagina or cervix.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
25
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (50)

Rush-Presbyterian-St. Luke's Medical Center

🇺🇸

Chicago, Illinois, United States

Johns Hopkins Oncology Center

🇺🇸

Baltimore, Maryland, United States

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

University of Colorado Cancer Center

🇺🇸

Denver, Colorado, United States

USC/Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Simmons Cancer Center - Dallas

🇺🇸

Dallas, Texas, United States

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Ireland Cancer Center

🇺🇸

Cleveland, Ohio, United States

Arthur G. James Cancer Hospital - Ohio State University

🇺🇸

Columbus, Ohio, United States

University of Oklahoma College of Medicine

🇺🇸

Oklahoma City, Oklahoma, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

Cancer Center, University of Virginia HSC

🇺🇸

Charlottesville, Virginia, United States

Cleveland Clinic Cancer Center

🇺🇸

Cleveland, Ohio, United States

Pennsylvania Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pennsylvania Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Tacoma General Hospital

🇺🇸

Tacoma, Washington, United States

University of Texas - MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Duke Comprehensive Cancer Center

🇺🇸

Durham, North Carolina, United States

Barrett Cancer Center, The University Hospital

🇺🇸

Cincinnati, Ohio, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Jonsson Comprehensive Cancer Center, UCLA

🇺🇸

Los Angeles, California, United States

Women's Cancer Center

🇺🇸

Palo Alto, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

H. Lee Moffitt Cancer Center and Research Institute

🇺🇸

Tampa, Florida, United States

Emory University Hospital - Atlanta

🇺🇸

Atlanta, Georgia, United States

MBCCOP - Hawaii

🇺🇸

Honolulu, Hawaii, United States

Albert B. Chandler Medical Center, University of Kentucky

🇺🇸

Lexington, Kentucky, United States

CCOP - Ann Arbor Regional

🇺🇸

Ann Arbor, Michigan, United States

University of Massachusetts Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

Barbara Ann Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

University of Minnesota Cancer Center

🇺🇸

Minneapolis, Minnesota, United States

Cancer Center of Albany Medical Center

🇺🇸

Albany, New York, United States

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

State University of New York Health Science Center at Brooklyn

🇺🇸

Brooklyn, New York, United States

University of Rochester Cancer Center

🇺🇸

Rochester, New York, United States

Lineberger Comprehensive Cancer Center, UNC

🇺🇸

Chapel Hill, North Carolina, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

Vincent T. Lombardi Cancer Research Center, Georgetown University

🇺🇸

Washington, District of Columbia, United States

University of Alabama Comprehensive Cancer Center

🇺🇸

Birmingham, Alabama, United States

Cooper Hospital/University Medical Center

🇺🇸

Camden, New Jersey, United States

University of Chicago Cancer Research Center

🇺🇸

Chicago, Illinois, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

Indiana University Cancer Center

🇺🇸

Indianapolis, Indiana, United States

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

State University of New York Health Sciences Center - Stony Brook

🇺🇸

Stony Brook, New York, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

© Copyright 2025. All Rights Reserved by MedPath